Zobrazeno 1 - 7
of 7
pro vyhledávání: '"R. Mateiro"'
Publikováno v:
European Psychiatry, Vol 65, Pp S713-S713 (2022)
Introduction Aripiprazole (ARI) is an atypical antipsychotic drug with D2 partial agonist properties, usually prescribed to treat mood disorders (major depression or bipolar disorder) and schizophrenic disorder (schizophrenia or schizoaffective disor
Externí odkaz:
https://doaj.org/article/119d5595db9146adbd58a15126c03ebd
Mental Health Refugees - Difficulties from the country of origin to the receiving country – A review
Publikováno v:
European Psychiatry, Vol 65, Pp S544-S545 (2022)
Introduction The most recent global refugee figures are staggering, with over 82.4 million people forcibly displaced as a result of persecution, conflict, violence, human rights violations. However, little is known about their long-term mental health
Externí odkaz:
https://doaj.org/article/ef1effb8bc4749938f74fcab6db33a08
Publikováno v:
European Psychiatry, Vol 65, Pp S716-S716 (2022)
Introduction Nitrous oxide (NO), also known as “laughing gas” is a colorless gas used as an anesthetic, a propellant in some foods, an engine performance enhancer and a recreational drug. When inhaled, it is known to provoke a rapid feeling of eu
Externí odkaz:
https://doaj.org/article/e77f2c389ca64f6d9493782cc305fb34
Publikováno v:
European Psychiatry, Vol 65, Pp S325-S325 (2022)
Introduction The COVID-19 pandemic and the lockdown brought about a sense of fear and anxiety around the globe. This phenomenon led to both short and long term psychosocial and mental health implications for children and adolescents. Objectives To e
Externí odkaz:
https://doaj.org/article/3fe92eaaa21b4ae6a9584962a9aef2fb
Publikováno v:
European Neuropsychopharmacology. 40:S288
Autor:
R. Mateiro, B. Costa Neves
Publikováno v:
European Neuropsychopharmacology. 26:S661-S662
Publikováno v:
European Psychiatry. 27:1
Objective and aims The authors intend to review clinical features, epidemiology and management of bipolar disorder in elderly patients, and discuss the possibility of a sub-classification as late-onset bipolar disorder, concerning a clinical case. Me